KIF1A相关的神经疾病:一种罕见突变性疾病的概述
Ayushi Nair1, Alosh Greeny1, Rajalakshmi Rajendran1
1Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita Health Science Campus, Kochi 682041, India.
Pharmaceuticals (Basel, Switzerland)
|June 1, 2023
概括
与KIF1A相关的神经系统疾病 (KANDs) 是由KIF1A基因突变引起的,破坏细胞运输并导致严重的儿科神经系统疾病. 基因疗法为治疗这些罕见的,经常被误诊的疾病提供了希望.
科学领域:
- 遗传学和分子生物学
- 神经科学是一个神经科学.
- 罕见疾病 罕见疾病
背景情况:
- 与KIF1A相关的神经疾病 (KAND) 是由KIF1A基因突变引起的遗传性疾病.
- 这些突变损害了KIF1A蛋白的功能,使其在细胞中必需的成分的前级运输中发挥作用,从而导致神经病理.
- 坎德病包括遗传性感官神经病变和性等疾病,在儿童时期经常出现不良预后.
研究的目的:
- 审查KIF1A相关的神经疾病的临床症状,病原和诊断方法.
- 探索当前的研究进展和KANDs的实验性基因治疗策略.
- 突出基因治疗在解决KANDs潜在遗传原因方面的潜力.
主要方法:
- 关于KIF1A相关的神经疾病的现有文献的综述.
- 讨论诊断工具,包括全外体序列测序 (WES).
- 分析各种基因治疗方式,如基因替代和基因淘汰.
主要成果:
- 基因KIF1A突变会破坏突触囊泡的运输,导致各种神经症状.
- 整体外体测序有助于诊断这些经常被误诊的疾病.
- 目前的治疗方法有限,没有可用的永久治疗方法.
结论:
- 基因疗法通过准根源的遗传原因,为治疗KANDs提供了一个有希望的途径.
- 进一步研究基因疗法方法,如基因替代和淘汰,至关重要.
- 开发有效的基因疗法可以显著有利于KAND患者及其家人.
相关概念视频
Parkinson's Disease: Overview
614
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
614
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K


